Despite Calls for a Moratorium, More ‘Three-Parent’ Babies Expected Soon
By Emily Mullin,
One Zero
| 09. 16. 2019
Clinics in Europe say they will continue offering a controversial IVF procedure
At least 10 babies have been born to apparently infertile women as a result of a controversial in vitro fertilization procedure that involves combining a mother’s egg with a donor one. The technique is often referred to as “three-person IVF” because the baby ends up with DNA from three people — the mother, the father, and an egg donor.
One of the births was reported in April by a Greek clinic performing the procedure, also known as mitochondrial replacement therapy, or mitochondrial donation. Now, fertility experts in Europe are calling for a moratorium on using the technique for women who have struggled to conceive.
The European Society of Human Reproduction and Embryology (ESHRE) has issued a statement urging “extreme caution” on the use of mitochondrial replacement for cases of infertility. The organization, which represents 8,000 clinicians and scientists, says there’s not enough evidence to show that it produces higher live-birth rates than conventional IVF. However, OneZero has learned that despite the group’s recommendation, the Greek clinic, as well as another center in Ukraine, will continue to offer the procedure —...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...